Gene · 710
Papers4,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 4,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| HOXA-AS2 may be a potential prognostic biomarker in human cancers: A meta-analysis and bioinformatics analysis. | Front Genet | 2022 | 36437956 | PubTator, text mining | PubMed |
| Prebiotic/probiotic supplementation resulted in reduced visceral fat and mRNA expression associated with adipose tissue inflammation, systemic inflammation, and chronic disease risk. | Genes Nutr | 2022 | 36437471 | PubTator, text mining | PubMed |
| SWATH Mass Spectrometry-Based CSF Proteome Profile of GBA-Linked Parkinson's Disease Patients. | Int J Mol Sci | 2022 | 36430645 | PubTator, text mining | PubMed |
| Biochemical Targets and Molecular Mechanism of Ginsenoside Compound K in Treating Osteoporosis Based on Network Pharmacology. | Int J Mol Sci | 2022 | 36430397 | PubTator, text mining | PubMed |
| Spontaneous Transformation of a p53 and Rb-Defective Human Fallopian Tube Epithelial Cell Line after Long Passage with Features of High-Grade Serous Carcinoma. | Int J Mol Sci | 2022 | 36430324 | PubTator, text mining | PubMed |
| Mass Spectrometry-Based Proteomic and Metabolomic Profiling of Serum Samples for Discovery and Validation of Tuberculosis Diagnostic Biomarker Signature. | Int J Mol Sci | 2022 | 36430211 | PubTator, text mining | PubMed |
| Altered Urinary Metabolomics in Hereditary Angioedema. | Metabolites | 2022 | 36422280 | PubTator, text mining | PubMed |
| Distinction of early complement classical and lectin pathway activation via quantification of C1s/C1-INH and MASP-1/C1-INH complexes using novel ELISAs. | Front Immunol | 2022 | 36420270 | PubTator, text mining | PubMed |
| Significance of urine complement proteins in monitoring lupus activity. | PeerJ | 2022 | 36420131 | PubTator, text mining | PubMed |
| MS-proteomics provides insight into the host responses towards alginate microspheres. | Mater Today Bio | 2022 | 36420052 | PubTator, text mining | PubMed |
| Lisinopril-Induced Small Bowel Angioedema: An Unusual Cause of Severe Abdominal Pain. | Am J Case Rep | 2022 | 36413511 | PubTator, text mining | PubMed |
| Bioinformatics Analysis to Find Novel Biomarkers for Coronary Heart Disease. | Iran J Public Health | 2022 | 36407720 | PubTator, text mining | PubMed |
| Extracellular vesicles biogenesis, isolation, manipulation and genetic engineering for potential in vitro and in vivo therapeutics: An overview. | Front Bioeng Biotechnol | 2022 | 36406206 | PubTator, text mining | PubMed |
| A rare association between factor H deficiency and lupus: Case report and experimental treatment with curcumin. | Front Pediatr | 2022 | 36405845 | PubTator, text mining | PubMed |
| Glioblastoma multiforme: Diagnosis, treatment, and invasion. | J Biomed Res | 2022 | 36403983 | PubTator, text mining | PubMed |
| Glycoproteomics revealed novel N-glycosylation biomarkers for early diagnosis of lung adenocarcinoma cancers. | Clin Proteomics | 2022 | 36401165 | PubTator, text mining | PubMed |
| Hereditary angioedema: A rare but serious and commonly misdiagnosed disease. | Nursing | 2022 | 36394625 | PubTator, text mining | PubMed |
| Long term follow-up of complement parameters to improve the management of acquired angioedema due to C1-inhibitor deficiency. | Heliyon | 2022 | 36387475 | PubTator, text mining | PubMed |
| Systematic pan-cancer analysis of the nicotinamide n-methyltransferase in human cancer. | Front Genet | 2022 | 36386816 | PubTator, text mining | PubMed |
| Leveraging the CSF proteome toward minimally-invasive diagnostics surveillance of brain malignancies. | Neurooncol Adv | 2022 | 36382110 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/710/papers?page=39